Skip to main content
Top
Published in: Journal of Cardiovascular Magnetic Resonance 1/2010

Open Access 01-12-2010 | Research

How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance

Authors: Tjeerd Germans, Iris K Rüssel, Marco JW Götte, Marieke D Spreeuwenberg, Pieter A Doevendans, Yigal M Pinto, Rob J van der Geest, Jolanda van der Velden, Arthur AM Wilde, Albert C van Rossum

Published in: Journal of Cardiovascular Magnetic Resonance | Issue 1/2010

Login to get access

Abstract

Background

Clinical data on myocardial function in HCM mutation carriers (carriers) is sparse but suggests that subtle functional abnormalities can be measured with tissue Doppler imaging before the development of overt hypertrophy. We aimed to confirm the presence of functional abnormalities using cardiovascular magnetic resonance (CMR), and to investigate if sensitive functional assessment could be employed to identify carriers.

Results

28 carriers and 28 controls were studied. Global left atrial (LA) and left ventricular (LV) dimensions, segmental peak systolic circumferential strain (SCS) and peak diastolic circumferential strain rate (DCSR), as well as the presence of late Gadolinium enhancement (LGE) were determined with CMR. Septal and lateral myocardial velocities were measured with echocardiographic tissue Doppler imaging. lv mass and volumes were comparable between groups. Maximal septal to lateral wall thickness ratio (SL ratio) was larger in carriers than in controls (1.3 ± 0.2 versus 1.1 ± 0.1, p < 0.001). Also, LA volumes were larger in carriers compared to controls (p < 0.05). Both peak SCS (p < 0.05) and peak DCSR (p < 0.01) were lower in carriers compared to controls, particularly in the basal lateral wall. Focal LGE was present in 2 carriers and not in controls. The combination of a SL ratio >1.2 and a peak DCSR <105%.s-1 was present in 45% of carriers and in none of the controls, yielding a positive predictive value of 100%. Two carriers and 18 controls had a SL ratio < 1.2 and peak DCSR >105%.s-1, yielding a negative predictive value of 90%. With multivariate analysis, HCM mutation carriership was an independent determinant of reduced peak SCS and peak DCSR.

Conclusions

HCM mutation carriership is an independent determinant of reduced peak SCS and peak DCSR when LV wall thickness is within normal limits, and is associated with increased LA volumes and SL ratio. Using SL ratio and peak DCSR has a high accuracy to identify carriers. However, since carriers also display structural abnormalities and focal LGE, we advocate to also evaluate morphology and presence of LGE when screening for carriers.
Appendix
Available only for authorised users
Literature
1.
go back to reference Maron BJ: Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002, 287: 1308-1320. 10.1001/jama.287.10.1308.PubMed Maron BJ: Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002, 287: 1308-1320. 10.1001/jama.287.10.1308.PubMed
2.
go back to reference Marian AJ: Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy. Lancet. 2000, 355: 58-60. 10.1016/S0140-6736(99)06187-5.CrossRefPubMed Marian AJ: Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy. Lancet. 2000, 355: 58-60. 10.1016/S0140-6736(99)06187-5.CrossRefPubMed
3.
go back to reference Fatkin D, McConnell BK, Mudd JO, Semsarian C, Moskowitz IG, Schoen FJ, Giewat M, Seidman CE, Seidman JG: An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy. J Clin Invest. 2000, 106: 1351-1359. 10.1172/JCI11093.PubMedCentralCrossRefPubMed Fatkin D, McConnell BK, Mudd JO, Semsarian C, Moskowitz IG, Schoen FJ, Giewat M, Seidman CE, Seidman JG: An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy. J Clin Invest. 2000, 106: 1351-1359. 10.1172/JCI11093.PubMedCentralCrossRefPubMed
4.
go back to reference Kataoka A, Hemmer C, Chase PB: Computational simulation of hypertrophic cardiomyopathy mutations in troponin I: influence of increased myofilament calcium sensitivity on isometric force, ATPase and [Ca2+]i. J Biomech. 2007, 40: 2044-2052. 10.1016/j.jbiomech.2006.09.026.CrossRefPubMed Kataoka A, Hemmer C, Chase PB: Computational simulation of hypertrophic cardiomyopathy mutations in troponin I: influence of increased myofilament calcium sensitivity on isometric force, ATPase and [Ca2+]i. J Biomech. 2007, 40: 2044-2052. 10.1016/j.jbiomech.2006.09.026.CrossRefPubMed
5.
go back to reference Geisterfer-Lowrance AA, Christe M, Conner DA, Ingwall JS, Schoen FJ, Seidman CE, Seidman JG: A mouse model of familial hypertrophic cardiomyopathy. Science. 1996, 272: 731-734. 10.1126/science.272.5262.731.CrossRefPubMed Geisterfer-Lowrance AA, Christe M, Conner DA, Ingwall JS, Schoen FJ, Seidman CE, Seidman JG: A mouse model of familial hypertrophic cardiomyopathy. Science. 1996, 272: 731-734. 10.1126/science.272.5262.731.CrossRefPubMed
6.
go back to reference Palmer BM, Noguchi T, Wang Y, Heim JR, Alpert NR, Burgon PG, Seidman CE, Seidman JG, Maughan DW, LeWinter MM: Effect of cardiac myosin binding protein-C on mechanoenergetics in mouse myocardium. Circ Res. 2004, 94: 1615-1622. 10.1161/01.RES.0000132744.08754.f2.CrossRefPubMed Palmer BM, Noguchi T, Wang Y, Heim JR, Alpert NR, Burgon PG, Seidman CE, Seidman JG, Maughan DW, LeWinter MM: Effect of cardiac myosin binding protein-C on mechanoenergetics in mouse myocardium. Circ Res. 2004, 94: 1615-1622. 10.1161/01.RES.0000132744.08754.f2.CrossRefPubMed
7.
go back to reference Pohlmann L, Kroger I, Vignier N, Schlossarek S, Kramer E, Coirault C, Sultan KR, El-Armouche A, Winegrad S, Eschenhagen T, Carrier L: Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes. Circ Res. 2007, 101: 928-938. 10.1161/CIRCRESAHA.107.158774.CrossRefPubMed Pohlmann L, Kroger I, Vignier N, Schlossarek S, Kramer E, Coirault C, Sultan KR, El-Armouche A, Winegrad S, Eschenhagen T, Carrier L: Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes. Circ Res. 2007, 101: 928-938. 10.1161/CIRCRESAHA.107.158774.CrossRefPubMed
8.
go back to reference Nagueh SF, Bachinski LL, Meyer D, Hill R, Zoghbi WA, Tam JW, Quiñones MA, Roberts R, Marian AJ: Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation. 2001, 104: 128-130.PubMedCentralCrossRefPubMed Nagueh SF, Bachinski LL, Meyer D, Hill R, Zoghbi WA, Tam JW, Quiñones MA, Roberts R, Marian AJ: Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation. 2001, 104: 128-130.PubMedCentralCrossRefPubMed
9.
go back to reference Ho CY, Sweitzer NK, McDonough B, Maron BJ, Casey SA, Seidman JG, Solomon SD: Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation. 2002, 105: 2992-2997. 10.1161/01.CIR.0000019070.70491.6D.CrossRefPubMed Ho CY, Sweitzer NK, McDonough B, Maron BJ, Casey SA, Seidman JG, Solomon SD: Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation. 2002, 105: 2992-2997. 10.1161/01.CIR.0000019070.70491.6D.CrossRefPubMed
10.
go back to reference Michels M, Soliman OI, Kofflard MJ, Hoedemaekers YM, Dooijes D, Majoor-Krakauer D, ten Cate FJ: Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations. JACC Cardiovasc Imaging. 2009, 2: 58-64. 10.1016/j.jcmg.2008.08.003.CrossRefPubMed Michels M, Soliman OI, Kofflard MJ, Hoedemaekers YM, Dooijes D, Majoor-Krakauer D, ten Cate FJ: Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations. JACC Cardiovasc Imaging. 2009, 2: 58-64. 10.1016/j.jcmg.2008.08.003.CrossRefPubMed
11.
go back to reference Zwanenburg JJ, Gotte MJ, Kuijer JP, Heethaar RM, van Rossum AC, Marcus JT: Timing of cardiac contraction in humans mapped by high-temporal-resolution MRI tagging: early onset and late peak of shortening in lateral wall. Am J Physiol Heart Circ Physiol. 2004, 286: H1872-H1880. 10.1152/ajpheart.01047.2003.CrossRefPubMed Zwanenburg JJ, Gotte MJ, Kuijer JP, Heethaar RM, van Rossum AC, Marcus JT: Timing of cardiac contraction in humans mapped by high-temporal-resolution MRI tagging: early onset and late peak of shortening in lateral wall. Am J Physiol Heart Circ Physiol. 2004, 286: H1872-H1880. 10.1152/ajpheart.01047.2003.CrossRefPubMed
12.
go back to reference Germans T, Wilde AA, Dijkmans PA, Chai W, Kamp O, Pinto YM, van Rossum AC: Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. J Am Coll Cardiol. 2006, 48: 2518-2523. 10.1016/j.jacc.2006.08.036.CrossRefPubMed Germans T, Wilde AA, Dijkmans PA, Chai W, Kamp O, Pinto YM, van Rossum AC: Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. J Am Coll Cardiol. 2006, 48: 2518-2523. 10.1016/j.jacc.2006.08.036.CrossRefPubMed
13.
go back to reference Germans T, Gotte MJ, Nijveldt R, Spreeuwenberg MD, Beek AM, Bronzwaer JG, Visser CA, Paulus WJ, van Rossum : Effects of aging on left atrioventricular coupling and left ventricular filling assessed using cardiac magnetic resonance imaging in healthy subjects. Am J Cardiol. 2007, 100: 122-127. 10.1016/j.amjcard.2007.02.060.CrossRefPubMed Germans T, Gotte MJ, Nijveldt R, Spreeuwenberg MD, Beek AM, Bronzwaer JG, Visser CA, Paulus WJ, van Rossum : Effects of aging on left atrioventricular coupling and left ventricular filling assessed using cardiac magnetic resonance imaging in healthy subjects. Am J Cardiol. 2007, 100: 122-127. 10.1016/j.amjcard.2007.02.060.CrossRefPubMed
14.
go back to reference Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM: Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999, 100: 1992-2002.CrossRefPubMed Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM: Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999, 100: 1992-2002.CrossRefPubMed
15.
go back to reference Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging: Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging. 2002, 18: 539-542.PubMed Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging: Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging. 2002, 18: 539-542.PubMed
16.
go back to reference Greenbaum RA, Ho SY, Gibson DG, Becker AE, Anderson RH: Left ventricular fibre architecture in man. Br Heart J. 1981, 45: 248-263. 10.1136/hrt.45.3.248.PubMedCentralCrossRefPubMed Greenbaum RA, Ho SY, Gibson DG, Becker AE, Anderson RH: Left ventricular fibre architecture in man. Br Heart J. 1981, 45: 248-263. 10.1136/hrt.45.3.248.PubMedCentralCrossRefPubMed
17.
go back to reference Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986, 1: 307-310.CrossRefPubMed Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986, 1: 307-310.CrossRefPubMed
18.
go back to reference Nijveldt R, Germans T, McCann GP, Beek AM, van Rossum AC: Semi-quantitative assessment of right ventricular function in comparison to a 3D volumetric approach: a cardiovascular magnetic resonance study. Eur Radiol. 2008, 18: 2399-2405. 10.1007/s00330-008-1017-7.CrossRefPubMed Nijveldt R, Germans T, McCann GP, Beek AM, van Rossum AC: Semi-quantitative assessment of right ventricular function in comparison to a 3D volumetric approach: a cardiovascular magnetic resonance study. Eur Radiol. 2008, 18: 2399-2405. 10.1007/s00330-008-1017-7.CrossRefPubMed
19.
go back to reference Hanley JA, McNeil BJ: A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983, 148: 839-843.CrossRefPubMed Hanley JA, McNeil BJ: A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983, 148: 839-843.CrossRefPubMed
20.
go back to reference Jongbloed RJ, Marcelis CL, Doevendans PA, Schmeitz-Mulkens JM, Van Dockum WG, Geraedts JP, Smeets HJ: Variable clinical manifestation of a novel missense mutation in the alpha-tropomyosin (TPM1) gene in familial hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003, 41: 981-986. 10.1016/S0735-1097(02)03005-X.CrossRefPubMed Jongbloed RJ, Marcelis CL, Doevendans PA, Schmeitz-Mulkens JM, Van Dockum WG, Geraedts JP, Smeets HJ: Variable clinical manifestation of a novel missense mutation in the alpha-tropomyosin (TPM1) gene in familial hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003, 41: 981-986. 10.1016/S0735-1097(02)03005-X.CrossRefPubMed
21.
go back to reference Alders M, Jongbloed R, Deelen W, van den WA, Doevendans P, Ten CF, Regitz-Zagrosek V, Vosberg HP, van Langen I, Wilde A, Dooijes D, Mannens M: The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands. Eur Heart J. 2003, 24: 1848-1853. 10.1016/S0195-668X(03)00466-4.CrossRefPubMed Alders M, Jongbloed R, Deelen W, van den WA, Doevendans P, Ten CF, Regitz-Zagrosek V, Vosberg HP, van Langen I, Wilde A, Dooijes D, Mannens M: The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands. Eur Heart J. 2003, 24: 1848-1853. 10.1016/S0195-668X(03)00466-4.CrossRefPubMed
22.
go back to reference Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP, Sivananthan MU: Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging. 2003, 17: 323-329. 10.1002/jmri.10262.CrossRefPubMed Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP, Sivananthan MU: Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging. 2003, 17: 323-329. 10.1002/jmri.10262.CrossRefPubMed
23.
go back to reference Nagueh SF, McFalls J, Meyer D, Hill R, Zoghbi WA, Tam JW, Quiñones MA, Roberts R, Marian AJ: Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease. Circulation. 2003, 108: 395-398. 10.1161/01.CIR.0000084500.72232.8D.PubMedCentralCrossRefPubMed Nagueh SF, McFalls J, Meyer D, Hill R, Zoghbi WA, Tam JW, Quiñones MA, Roberts R, Marian AJ: Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease. Circulation. 2003, 108: 395-398. 10.1161/01.CIR.0000084500.72232.8D.PubMedCentralCrossRefPubMed
24.
go back to reference Cazorla O, Szilagyi S, Vignier N, Salazar G, Kramer E, Vassort G, Carrier L, Lacampagne A: Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice. Cardiovasc Res. 2006, 69: 370-380. 10.1016/j.cardiores.2005.11.009.CrossRefPubMed Cazorla O, Szilagyi S, Vignier N, Salazar G, Kramer E, Vassort G, Carrier L, Lacampagne A: Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice. Cardiovasc Res. 2006, 69: 370-380. 10.1016/j.cardiores.2005.11.009.CrossRefPubMed
25.
go back to reference Robinson P, Griffiths PJ, Watkins H, Redwood CS: Dilated and Hypertrophic Cardiomyopathy Mutations in Troponin and alpha-Tropomyosin Have Opposing Effects on the Calcium Affinity of Cardiac Thin Filaments. Circ Res. 2007, 101: 1266-1273. 10.1161/CIRCRESAHA.107.156380.CrossRefPubMed Robinson P, Griffiths PJ, Watkins H, Redwood CS: Dilated and Hypertrophic Cardiomyopathy Mutations in Troponin and alpha-Tropomyosin Have Opposing Effects on the Calcium Affinity of Cardiac Thin Filaments. Circ Res. 2007, 101: 1266-1273. 10.1161/CIRCRESAHA.107.156380.CrossRefPubMed
26.
go back to reference Stelzer JE, Patel JR, Walker JW, Moss RL: Differential roles of cardiac myosin-binding protein C and cardiac troponin I in the myofibrillar force responses to protein kinase A phosphorylation. Circ Res. 2007, 101: 503-511. 10.1161/CIRCRESAHA.107.153650.CrossRefPubMed Stelzer JE, Patel JR, Walker JW, Moss RL: Differential roles of cardiac myosin-binding protein C and cardiac troponin I in the myofibrillar force responses to protein kinase A phosphorylation. Circ Res. 2007, 101: 503-511. 10.1161/CIRCRESAHA.107.153650.CrossRefPubMed
27.
go back to reference Kehr E, Sono M, Chugh SS, Jerosch-Herold M: Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro. Int J Cardiovasc Imaging. 2008, 24: 61-68. 10.1007/s10554-007-9223-y.CrossRefPubMed Kehr E, Sono M, Chugh SS, Jerosch-Herold M: Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro. Int J Cardiovasc Imaging. 2008, 24: 61-68. 10.1007/s10554-007-9223-y.CrossRefPubMed
28.
go back to reference Knaapen P, van Dockum WG, Bondarenko O, Kok WE, Gotte MJ, Boellaard R, Beek AM, Visser CA, van Rossum AC, Lammertsma AA, Visser FC: Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET. J Nucl Med. 2005, 46: 923-929.PubMed Knaapen P, van Dockum WG, Bondarenko O, Kok WE, Gotte MJ, Boellaard R, Beek AM, Visser CA, van Rossum AC, Lammertsma AA, Visser FC: Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET. J Nucl Med. 2005, 46: 923-929.PubMed
29.
go back to reference Konno T, Shimizu M, Ino H, Fujino N, Hayashi K, Uchiyama K, Kaneda T, Inoue M, Fujita T, Masuta E, Funada A, Mabuchi H: Differences in diagnostic value of four electrocardiographic voltage criteria for hypertrophic cardiomyopathy in a genotyped population. Am J Cardiol. 2005, 96: 1308-1312. 10.1016/j.amjcard.2005.06.078.CrossRefPubMed Konno T, Shimizu M, Ino H, Fujino N, Hayashi K, Uchiyama K, Kaneda T, Inoue M, Fujita T, Masuta E, Funada A, Mabuchi H: Differences in diagnostic value of four electrocardiographic voltage criteria for hypertrophic cardiomyopathy in a genotyped population. Am J Cardiol. 2005, 96: 1308-1312. 10.1016/j.amjcard.2005.06.078.CrossRefPubMed
30.
go back to reference Strijack B, Ariyarajah V, Soni R, Jassal DS, Greenberg CR, McGregor R, Morris A: Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype. J Cardiovasc Magn Reson. 2008, 10: 58-10.1186/1532-429X-10-58.PubMedCentralCrossRefPubMed Strijack B, Ariyarajah V, Soni R, Jassal DS, Greenberg CR, McGregor R, Morris A: Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype. J Cardiovasc Magn Reson. 2008, 10: 58-10.1186/1532-429X-10-58.PubMedCentralCrossRefPubMed
Metadata
Title
How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance
Authors
Tjeerd Germans
Iris K Rüssel
Marco JW Götte
Marieke D Spreeuwenberg
Pieter A Doevendans
Yigal M Pinto
Rob J van der Geest
Jolanda van der Velden
Arthur AM Wilde
Albert C van Rossum
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Cardiovascular Magnetic Resonance / Issue 1/2010
Electronic ISSN: 1532-429X
DOI
https://doi.org/10.1186/1532-429X-12-13

Other articles of this Issue 1/2010

Journal of Cardiovascular Magnetic Resonance 1/2010 Go to the issue